AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
PROFOUND HYPONATREMIA FOLLOWING AN IDIOSYNCRATIC REACTION TO DIURETICS
Authors: WIERZBICKI AS BALL SG SINGH NKP
Citation: As. Wierzbicki et al., PROFOUND HYPONATREMIA FOLLOWING AN IDIOSYNCRATIC REACTION TO DIURETICS, International journal of clinical practice, 52(4), 1998, pp. 278-279
HIGH-DOSE ATORVASTATIN THERAPY IN SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Authors: WIERZBICKI AS LUMB PJ SEMRA YK CROOK MA
Citation: As. Wierzbicki et al., HIGH-DOSE ATORVASTATIN THERAPY IN SEVERE HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 91(4), 1998, pp. 291-294
PEOPLE AT RISK OF CORONARY HEART-DISEASE SHOULD NOT BE DENIED TREATMENT WITH EFFECTIVE DRUGS FOR PURELY FINANCIAL REASONS
Authors: REYNOLDS TM WIERZBICKI AS CROOK MA CAPPS NE
Citation: Tm. Reynolds et al., PEOPLE AT RISK OF CORONARY HEART-DISEASE SHOULD NOT BE DENIED TREATMENT WITH EFFECTIVE DRUGS FOR PURELY FINANCIAL REASONS, BMJ. British medical journal, 317(7150), 1998, pp. 80-80
LIPID-LOWERING THERAPY IN PATIENTS WITH HIV-INFECTION
Authors: WIERZBICKI AS REYNOLDS TM CROOK MA TATLER J PETERS BS
Citation: As. Wierzbicki et al., LIPID-LOWERING THERAPY IN PATIENTS WITH HIV-INFECTION, Lancet, 352(9142), 1998, pp. 1782-1782
STATINS AND FIBRINOGEN - REPLY
Authors: WIERZBICKI AS CROOK MA
Citation: As. Wierzbicki et Ma. Crook, STATINS AND FIBRINOGEN - REPLY, Lancet, 351(9113), 1998, pp. 1431-1432
EFFECT OF ATORVASTATIN ON PLASMA-FIBRINOGEN
Authors: WIERZBICKI AS LUMB PJ SEMRA YK CROOK MA
Citation: As. Wierzbicki et al., EFFECT OF ATORVASTATIN ON PLASMA-FIBRINOGEN, Lancet, 351(9102), 1998, pp. 569-570
INFLUENCE OF PLASMA PHYTANIC ACID LEVELS IN REFSUMS-DISEASE ON THE BEHAVIOR OF THE ERYTHROCYTE-MEMBRANE SODIUM-LITHIUM COUNTERTRANSPORTER
Authors: WIERZBICKI AS HARDMAN TC LUMB P SANKARALINGAM A MORRISH Z PATEL F SIDEY MC GIBBERD FB
Citation: As. Wierzbicki et al., INFLUENCE OF PLASMA PHYTANIC ACID LEVELS IN REFSUMS-DISEASE ON THE BEHAVIOR OF THE ERYTHROCYTE-MEMBRANE SODIUM-LITHIUM COUNTERTRANSPORTER, European journal of clinical investigation, 28(4), 1998, pp. 334-338
LABORATORY INVESTIGATIONS BY DNA AMPLIFICATION - FROM RESEARCH TO PRACTICE
Authors: WIERZBICKI AS
Citation: As. Wierzbicki, LABORATORY INVESTIGATIONS BY DNA AMPLIFICATION - FROM RESEARCH TO PRACTICE, Annals of clinical biochemistry, 35, 1998, pp. 5-11
DIAGNOSIS AND MANAGEMENT OF HYPERLIPIDEMIA
Authors: WIERZBICKI AS
Citation: As. Wierzbicki, DIAGNOSIS AND MANAGEMENT OF HYPERLIPIDEMIA, International journal of clinical practice, 51(6), 1997, pp. 378-383
FENOFIBRATE PLUS SIMVASTATIN THERAPY VERSUS SIMVASTATIN PLUS CHOLESTYRAMINE THERAPY FOR FAMILIAL HYPERCHOLESTEROLEMIA
Authors: WIERZBICKI AS LUMB PJ CHEUNG J CROOK MA
Citation: As. Wierzbicki et al., FENOFIBRATE PLUS SIMVASTATIN THERAPY VERSUS SIMVASTATIN PLUS CHOLESTYRAMINE THERAPY FOR FAMILIAL HYPERCHOLESTEROLEMIA, Quarterly Journal of Medicine, 90(10), 1997, pp. 631-634
USE OF STATINS - GUIDELINES NEED TO CONCENTRATE ON REDUCING OVERALL CARDIOVASCULAR RISK
Authors: WIERZBICKI AS REYNOLDS TM
Citation: As. Wierzbicki et Tm. Reynolds, USE OF STATINS - GUIDELINES NEED TO CONCENTRATE ON REDUCING OVERALL CARDIOVASCULAR RISK, BMJ. British medical journal, 315(7122), 1997, pp. 1616-1617
PRESERVED ENDOTHELIAL FUNCTION IN PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA AND LOW FUNCTIONAL LIPOPROTEIN-LIPASE ACTIVITY
Authors: CHOWIENCZYK PJ WATTS GF WIERZBICKI AS COCKCROFT JR BRETT SE RITTER JM
Citation: Pj. Chowienczyk et al., PRESERVED ENDOTHELIAL FUNCTION IN PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA AND LOW FUNCTIONAL LIPOPROTEIN-LIPASE ACTIVITY, Journal of the American College of Cardiology, 29(5), 1997, pp. 964-968
FENOFIBRATE-SIMVASTATIN THERAPY COMPARED TO SIMVASTATIN-RESIN THERAPYAND ATORVASTATIN FOR FAMILIAL HYPERCHOLESTEROLEMIA
Authors: WIERZBICKI AS LUMB PJ CHEUNG J CROOK MA
Citation: As. Wierzbicki et al., FENOFIBRATE-SIMVASTATIN THERAPY COMPARED TO SIMVASTATIN-RESIN THERAPYAND ATORVASTATIN FOR FAMILIAL HYPERCHOLESTEROLEMIA, Atherosclerosis, 134(1-2), 1997, pp. 63-63
HYPERLIPIDEMIA IN ASSOCIATION WITH BENIGN PARAPROTEINEMIA
Authors: JOHNSTON JD LUMB PJ WIERZBICKI AS
Citation: Jd. Johnston et al., HYPERLIPIDEMIA IN ASSOCIATION WITH BENIGN PARAPROTEINEMIA, Annals of clinical biochemistry, 34, 1997, pp. 697-699
CARDIAC TROPONIN-T IN UNSTABLE ANGINA - TROPONIN-T COULD BE USED TO IDENTIFY PATIENTS NEEDING EARLY TREATMENT
Authors: WIERZBICKI AS REYNOLDS TM
Citation: As. Wierzbicki et Tm. Reynolds, CARDIAC TROPONIN-T IN UNSTABLE ANGINA - TROPONIN-T COULD BE USED TO IDENTIFY PATIENTS NEEDING EARLY TREATMENT, BMJ. British medical journal, 313(7068), 1996, pp. 1330-1330
COST-EFFECTIVENESS OF LOWERING CHOLESTEROL - FULL TREATMENT OF THE COSTS AND BENEFITS IS NEEDED
Authors: WIERZBICKI AS REYNOLDS TM
Citation: As. Wierzbicki et Tm. Reynolds, COST-EFFECTIVENESS OF LOWERING CHOLESTEROL - FULL TREATMENT OF THE COSTS AND BENEFITS IS NEEDED, BMJ. British medical journal, 313(7065), 1996, pp. 1143-1143
ANGIOTENSIN-CONVERTING ENZYME (ACE) GENE POLYMORPHISM AND THE ERYTHROCYTE SODIUM-LITHIUM COUNTERTRANSPORTER (SLC) PHENOTYPE IN HYPERTENSION
Authors: HARDMAN TC WIERZBICKI AS CROFT P FEHER M COX A LANT AF
Citation: Tc. Hardman et al., ANGIOTENSIN-CONVERTING ENZYME (ACE) GENE POLYMORPHISM AND THE ERYTHROCYTE SODIUM-LITHIUM COUNTERTRANSPORTER (SLC) PHENOTYPE IN HYPERTENSION, Journal of human hypertension, 10(6), 1996, pp. 429-430
MEASUREMENT OF SODIUM-LITHIUM COUNTERTRANSPORT KINETICS
Authors: WIERZBICKI AS
Citation: As. Wierzbicki, MEASUREMENT OF SODIUM-LITHIUM COUNTERTRANSPORT KINETICS, Hypertension, 27(2), 1996, pp. 315-315
FAMILIAL HYPERCHYLOMICRONEMIA
Authors: WIERZBICKI AS REYNOLDS TM
Citation: As. Wierzbicki et Tm. Reynolds, FAMILIAL HYPERCHYLOMICRONEMIA, Lancet, 348(9040), 1996, pp. 1524-1524
SHEFFIELD RISK AND TREATMENT TABLE FOR PRIMARY PREVENTION OF CORONARYHEART-DISEASE
Authors: WIERZBICKI AS REYNOLDS TM
Citation: As. Wierzbicki et Tm. Reynolds, SHEFFIELD RISK AND TREATMENT TABLE FOR PRIMARY PREVENTION OF CORONARYHEART-DISEASE, Lancet, 348(9033), 1996, pp. 1039-1040
SHEFFIELD RISK AND TREATMENT TABLE FOR CHOLESTEROL-LOWERING IN PREVENTION OF CORONARY HEART-DISEASE
Authors: WIERZBICKI AS REYNOLDS TM
Citation: As. Wierzbicki et Tm. Reynolds, SHEFFIELD RISK AND TREATMENT TABLE FOR CHOLESTEROL-LOWERING IN PREVENTION OF CORONARY HEART-DISEASE, Lancet, 347(8999), 1996, pp. 466-467
PATIENTS WITH RECURRENT RENAL STONES HAVE A PHYSICOCHEMICALLY ALTEREDURINARY TAMM-HORSFALL GLYCOPROTEIN PROFILE
Authors: JEFFERSON A REYNOLDS TM ELVES A WIERZBICKI AS
Citation: A. Jefferson et al., PATIENTS WITH RECURRENT RENAL STONES HAVE A PHYSICOCHEMICALLY ALTEREDURINARY TAMM-HORSFALL GLYCOPROTEIN PROFILE, Annals of clinical biochemistry, 33, 1996, pp. 540-544
STRATEGIES FOR REDUCING CORONARY RISK-FACTORS IN PRIMARY-CARE
Authors: WIERZBICKI AS REYNOLDS TM
Citation: As. Wierzbicki et Tm. Reynolds, STRATEGIES FOR REDUCING CORONARY RISK-FACTORS IN PRIMARY-CARE, BMJ. British medical journal, 311(6999), 1995, pp. 263-263
HEALTH PROMOTION IN GENERAL-PRACTICE - ANY BENEFICIAL EFFECT WAS LOSTIN BACKGROUND STATISTICAL NOISE
Authors: WIERZBICKI AS REYNOLDS TM
Citation: As. Wierzbicki et Tm. Reynolds, HEALTH PROMOTION IN GENERAL-PRACTICE - ANY BENEFICIAL EFFECT WAS LOSTIN BACKGROUND STATISTICAL NOISE, BMJ. British medical journal, 310(6978), 1995, pp. 532-533
ASSOCIATION OF ANGIOTENSIN-CONVERTING ENZYME-DD GENOTYPE WITH HYPERTENSION IN DIABETES
Authors: WIERZBICKI AS NIMMO L FEHER MD COX A FOXTON J LANT AF
Citation: As. Wierzbicki et al., ASSOCIATION OF ANGIOTENSIN-CONVERTING ENZYME-DD GENOTYPE WITH HYPERTENSION IN DIABETES, Journal of human hypertension, 9(8), 1995, pp. 671-673
Risultati: 1-25 | 26-35